FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Hisamitsu Pharmaceutical Co., Inc. Stock AnalysisComprehensive stock analysis for Hisamitsu Pharmaceutical Co., Inc. (HTSUF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisHTSUF
HTSUF
Hisamitsu Pharmaceutical Co., Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
HTSUF
Home🔹Stocks🔹Hisamitsu Pharmaceutical Co., Inc.

Hisamitsu Pharmaceutical Co., Inc.

HTSUF•OTC

Hisamitsu Pharmaceutical Co., Inc.

HTSUF•OTC
Market cap
$2.03B
Sentiment

Your view on HTSUF

Mkt Cap
$2.03B
Sentiment
Your view
HTSUF
Hisamitsu Pharmaceutical Co., Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
HTSUF
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Hisamitsu Pharmaceutical Co., Inc.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Kazuhide Nakatomi
Headquarters
408, Tashiro Daikan-machi, Tosu, JP
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Kazuhide Nakatomi
Headquarters
408, Tashiro Daikan-machi, Tosu, JP
Description

Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; and BUTENALOCK, a remedy for athlete's foot, as well as ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, transdermal analgesic anti-inflammatory drug; patches for female hormone, asthma treatment, and treatment for overactive bladders. In addition, the company manufactures and sells drugs under MOHRUS TAPE, MOHRUS PAP XR, FENTOS Tapes, NEOXY Tapes, Abstral, ALLESAGA Tapes, HARUROPI Tapes, and MENOAID Combipatch. Further, it provides HFT-290, a transdermal patch for cancer pain. The company sells its products in the United States and Asia. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News